I05-I09

Chronic rheumatic heart diseases

Chronic rheumatic heart diseases (I05-I09) represent a cluster of permanent cardiac valvular conditions that arise as long-term sequelae of acute rheumatic fever. This inflammatory process is triggered by an autoimmune response following a Group A streptococcal (S. pyogenes) pharyngeal infection, typically in childhood or adolescence. The pathogenesis involves molecular mimicry, where antibodies produced against streptococcal M-proteins cross-react with cardiac myosin and valvular tissues. Over years or decades, this repeated or chronic inflammation leads to progressive thickening, fibrosis, and calcification of the heart valves, as well as fusion of the commissures and shortening of the chordae tendineae. The mitral valve is most frequently affected (approximately 70% of cases), followed by the aortic valve. These structural changes result in mechanical dysfunction, manifesting as valvular stenosis, regurgitation, or both. If left untreated, chronic rheumatic heart disease often progresses to congestive heart failure, pulmonary hypertension, atrial fibrillation, and increased risk for thromboembolic events such as stroke.

Clinical Symptoms

Progressive dyspnea on exertion
Orthopnea (difficulty breathing when lying flat)
Paroxysmal nocturnal dyspnea
Chronic fatigue and exercise intolerance
Palpitations and irregular heart rhythms (especially atrial fibrillation)
Peripheral edema (swelling of ankles and feet)
Ascites and abdominal distension
Hemoptysis (coughing up blood, commonly seen in mitral stenosis)
Angina-like chest pain
Presyncope or syncope (fainting), particularly with aortic valve involvement
Audible heart murmurs (systolic or diastolic)
Hepatomegaly (enlarged liver due to venous congestion)
Jugular venous distension
Signs of systemic embolism (e.g., neurological deficits from stroke)

Common Causes

History of acute rheumatic fever (ARF)
Untreated or inadequately treated Group A streptococcal pharyngitis (S. pyogenes)
Autoimmune cross-reactivity (molecular mimicry) between streptococcal antigens and cardiac tissue
Repeated streptococcal infections leading to recurrent episodes of valvulitis
Chronic inflammatory remodeling of the endocardial and valvular structures
Genetic predisposition, specifically associated with certain HLA-DR class II alleles
Environmental risk factors including overcrowding and poor access to antibiotic treatment

Documentation & Coding Tips

Explicitly differentiate between rheumatic and non-rheumatic valvular disease to ensure correct code selection from the I05-I09 series.

Example: Patient with a childhood history of acute rheumatic fever presents with worsening dyspnea. Echocardiogram confirms severe rheumatic mitral stenosis with a valve area of 0.9 cm2 and mild rheumatic tricuspid insufficiency. Chronic rheumatic heart disease is the primary driver of current heart failure symptoms. Management includes diuretics and consultation for valvuloplasty. Billing focuses on identifying both the mitral and tricuspid valves as rheumatic in origin. Risk adjustment is captured via the HCC mapping for chronic rheumatic valvular disease.

Billing Focus: Specific valve identification (mitral, aortic, tricuspid) and confirmation of rheumatic etiology.

Document all involved valves when multiple valves are affected, as this utilizes combined codes like I08.0.

Example: 65-year-old male with chronic rheumatic heart disease involving both the mitral and aortic valves. Current assessment reveals rheumatic mitral insufficiency and rheumatic aortic stenosis. Patient is categorized as NYHA Class III heart failure. Billing requires the use of I08.0 to represent the multi-valvular nature of the rheumatic disease. Risk adjustment reflects the increased complexity of managing multiple stenotic or regurgitant valves.

Billing Focus: Use of combination codes (I08.x) for multi-valvular involvement instead of individual codes when applicable.

Link secondary conditions such as atrial fibrillation or heart failure directly to the chronic rheumatic heart disease when a causal relationship exists.

Example: The patient's permanent atrial fibrillation is secondary to left atrial enlargement caused by long-standing chronic rheumatic mitral stenosis. Heart failure with preserved ejection fraction is also documented as a complication of the rheumatic valvular pathology. Billing includes I05.0 for mitral stenosis and I48.21 for permanent atrial fibrillation. Risk adjustment is enhanced by documenting the causal link between the valve disease and the rhythm disturbance.

Billing Focus: Coding for associated complications (e.g., I48.x for AFib, I50.x for Heart Failure) alongside the primary rheumatic code.

Specify the presence of pulmonary hypertension if it has developed as a result of chronic rheumatic heart disease.

Example: Patient with chronic rheumatic mitral stenosis and insufficiency now demonstrating Group 2 pulmonary hypertension (I27.22). Documentation reflects that the pulmonary hypertension is a direct consequence of elevated left-sided pressures from rheumatic mitral disease. Billing focuses on the specific type of pulmonary hypertension. Risk adjustment accounts for the presence of secondary pulmonary vascular disease.

Billing Focus: Inclusion of I27.22 for pulmonary hypertension secondary to left heart disease.

Clarify the status of valve replacements if the patient has undergone surgery for rheumatic disease.

Example: Follow-up for a patient with a history of rheumatic aortic stenosis, status post mechanical aortic valve replacement (Z95.2). The patient continues to require anticoagulation management for the prosthetic valve. Documentation must reflect the history of rheumatic disease even if the native valve is gone to justify the ongoing medical necessity. Billing includes the status code Z95.2 and the original rheumatic condition code if still being managed.

Billing Focus: Use of Z-codes for prosthetic valves and specific codes for the management of the mechanical valve.

Relevant CPT Codes

93306 - Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography
Primary diagnostic tool to assess valve morphology, severity of stenosis or regurgitation, and cardiac function in rheumatic heart disease.
99214 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a moderate level of medical decision making
Typically used for routine follow-up of stable chronic rheumatic heart disease with management of medications like diuretics or anticoagulants.
99215 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a high level of medical decision making
Used for patients with advanced rheumatic heart disease experiencing acute decompensation or requiring complex surgical planning.
99213 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a low level of medical decision making
Used for monitoring stable patients with mild rheumatic valve changes and no significant symptoms.
93000 - Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report
Necessary to screen for atrial fibrillation and chamber enlargement commonly seen in chronic rheumatic heart disease.
33425 - Valvuloplasty, mitral valve, with supravalvular ring
Surgical intervention required for severe rheumatic mitral disease when the valve is amenable to repair.
33430 - Replacement, mitral valve, with cardiopulmonary bypass
The definitive treatment for rheumatic mitral valves that are too damaged for repair.
33405 - Replacement, aortic valve, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve
Standard treatment for rheumatic aortic stenosis or regurgitation.
93312 - Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report
Used to better visualize the valve prior to surgery or to rule out left atrial thrombus in patients with rheumatic mitral stenosis and AFib.
93458 - Catheter placement in coronary artery(s) for selective coronary angiography, with catheter placement(s) in left ventricle(s), including intraprocedural injection(s) for left ventriculography, imaging supervision and interpretation
Performed prior to valve surgery to assess coronary anatomy and confirm hemodynamic measurements of valve gradients.